| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |